AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
62.72
+0.35 (0.57%)
At close: Mar 23, 2026, 4:00 PM EDT
63.66
+0.94 (1.50%)
After-hours: Mar 23, 2026, 6:57 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $1.8 billion as of March 23, 2026. Its market cap has increased by 258.54% in one year.
Market Cap
1.80B
Enterprise Value
1.78B
1-Year Change
258.54%
Ranking
Category
Stock Price
$62.72
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $1.80B, an increase of 484.09%. That is a compound annual growth rate of 21.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 1.79B | 33.57% |
| Dec 31, 2025 | 1.34B | 233.16% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
| Jan 26, 2017 | 308.70M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurinia Pharmaceuticals | 1.86B |
| Mesoblast | 1.85B |
| Definium Therapeutics | 1.83B |
| Ocular Therapeutix | 1.78B |
| Ascentage Pharma Group International | 1.78B |
| Relay Therapeutics | 1.77B |
| Sarepta Therapeutics | 1.75B |
| Enliven Therapeutics | 1.74B |